Slide 1: 2Q Fiscal 2024 Webcast
2Q Fiscal 2024 Webcast May 21, 2024 NBS NEXT OWNER MINDSET WINNING TEAMS
Slide 2: Safe Harbor Statement
Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by
Slide 3: Agenda
Agenda 2Q 2024 Webcast – May 21, 2024 2nd Quarter Highlights Market Outlook Sales Performance and Earnings Review FY 2024 and 3Q 2024 Guidance Balance Sheet and Cash Flow Q&A Sundaram Nagarajan Stephen Shamrock Lara Mahoney President and Chief Accounting Officer Vice President, 3 Chief E
Slide 4: Dan Hopgood, EVP and Chief Financial Officer
Dan Hopgood, EVP and Chief Financial Officer Joined Nordson May 20, 2024 Brings more than 25 years of financial and operational expertise to Nordson Most recently Controller and Chief Accounting Officer at Eaton Corporation, a $23 billion multinational power management company 4
Slide 5: 2Q24 Highlights
Sales of $651 million driven by 2Q24 Highlights ARAG acquisition and growth in industrial coatings systems and fluid solutions product lines Solid operating performance driven by NBS Next Growth Framework Free cash flow of $108 million, 92% of net income Paid down nearly $100 million of debt
Slide 6: Total Company – 2Q 2024
Total Company – 2Q 2024 Sales 2Q 2024 Sales Bridge** Reported sales of $651 million, comparable to prior year 5% growth from ARAG acquisition 4% organic decrease driven by electronics, partially offset by growth in industrial coatings systems and fluid solutions product lines EBITDA* 2Q 2023 2
Slide 7: Industrial Precision Solutions – 2Q 2024
Industrial Precision Solutions – 2Q 2024 2Q 2024 IPS Sales Bridge Sales Sales of $367 million, increased 9% Organic growth of 2% driven primarily by industrial coatings systems and packaging product lines EBITDA* EBITDA and Margin* EBITDA was $132 million, or 36% of sales $132 EBITDA growth
Slide 8: Medical and Fluid Solutions – 2Q 2024
Medical and Fluid Solutions – 2Q 2024 Sales 2Q 2024 MFS Sales Bridge Sales of $169 million, increased 2% Organic sales increase of 2% Increase was driven by growth in the fluid and medical interventional solutions product lines EBITDA* EBITDA and Margin* $72 EBITDA was $63 million, 37% of sa
Slide 9: Advanced Technology Solutions – 2Q 2024
Advanced Technology Solutions – 2Q 2024 Sales 2Q 2024 ATS Sales Bridge Sales were $115 million, a 22% decrease The organic sales decrease was driven by weakness across the segment EBITDA* EBITDA and Margin* EBITDA was $24 million, or 21% of sales $42 $32 Decrease was driven primarily by lowe
Slide 10: Balance Sheet and Cash Flow
Balance Sheet and Cash Flow Strong Cash Flow with Sufficient Liquidity to Invest in Strategic Initiatives Net Debt Free Cash Flow Cash totaled $125 million Free cash flow of $108 million, which is a conversion rate of 92% of net income Repaid ~$100 million of debt in the quarter Dividend pay
Slide 11: End Market Visibility
End Market Visibility Industrial Precision Solutions Medical and Fluid Solutions Advanced Technology Solutions • Steady demand in industrials and • Sequential order-pick up in medical fluid • Continued weakness in orders related to consumer non-durable product lines components the electronics cycle
Slide 12: Full-Year Fiscal 2024 Guidance
Full-Year Fiscal 2024 Guidance Full-Year Sales Guidance Updating guidance $2,629 $2,630 - $2,680 $2,590 Backlog continues to normalize at $700 million Fiscal 2024 sales of flat to 2% over record prior year Adjusted earnings in the range of $9.35 to $9.75 2022 2023 2024 Full-Year Adjusted EPS G
Slide 13: 3Q Fiscal 2024 Guidance
3Q Fiscal 2024 Guidance 3Q 2024 Sales Guidance $645 - $670 Steady performance moving into $662 $649 3Q 3Q 24 sales of $645 - $670 million 3Q 24 adjusted earnings per share in the range of $2.25 - $2.40 3Q 22 3Q 23 3Q 24 3Q 2024 Adjusted EPS Guidance* $2.49 $2.25 - $2.40 $2.35 13 *Non-GAAP number
Slide 14: Questions?
Questions? Giordson
Slide 15: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Net Income to Adjusted EBITDA (Dollars in thousands) 15
Slide 16: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 16
Slide 17: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 17